Interestingly, although loss of CD11b+ DC in the subepithelial do

Interestingly, although loss of CD11b+ DC in the subepithelial dome of the PP has been suggested to cause an incapacity to mount antigen-specific IgA responses in CCR6−/− mice,28 PP is the only GALT in CD47−/− mice that does not have a reduced frequency of this DC subset (before and after administration of CT). Apoptosis inhibitor In addition, in CD47−/− chimeric

mice reconstituted with WT BM, the frequency of DC is restored to WT levels in the spleen with a similar trend in the MLN. Despite this the capacity to generate OVA-specific intestinal IgA following oral immunization with OVA and CT is not regained. Therefore, the defect in OVA-specific IgA production is unlikely to be linked to the reduced frequency of CD11b+ DC, but is rather the result of the lack of CD47 expression by non-haematopoietic cells. In addition to defective activation of CD4+ T cells in www.selleckchem.com/products/Cilomilast(SB-207499).html CD47−/− mice, another reason

for the reduced levels of OVA-specific intestinal IgA could be that IgA-secreting plasma cells generated in the PP do not properly home to the intestine in CD47−/− mice. This is consistent with the fact that the frequency of OVA-specific IgA-producing cells in the intestine is reduced in CD47−/− mice following immunization with OVA and CT. Entry of plasma cells into peripheral tissues requires extravasation across the blood endothelial wall. As endothelial cells express CD172a, it is possible that interactions between leucocyte CD47 and CD172a on vascular endothelial cells is important

for leucocyte transmigration, resulting in impaired ability of plasma cells generated in GALT to leave the circulation and efficiently home to the intestinal tissue in the absence of this bi-directional interaction. Buspirone HCl In addition, it has been shown that integrin-mediated phosphorylation of CD172a in endothelial cells is greatly reduced if the cells also lack CD47, which could have an impact on endothelial permeability.12 Hence, integrin-mediated transmigration could be hampered even if the leucocyte expresses CD47 if the endothelial cell still lacks this protein. This could possibly explain why reduced levels of anti-OVA-specific IgA are still generated in CD47−/− mice whose haematopoietic compartment is replaced with CD47-sufficient cells. This is also consistent with the normal levels of OVA-specific serum IgA and IgG in CD47−/− mice, as plasma cells secreting these immunoglobulins can reside in the BM without homing to the intestine. A third explanation for the reduced levels of intestinal anti-OVA IgA is the reduced number of cells in the intestinal tissue in CD47−/− mice. The reduction of cells in GALT was not due to one specific cell type.

In addition, they have been suggested for risk evaluation [85] S

In addition, they have been suggested for risk evaluation [85]. Several other mAbs are being investigated in clinical programmes or used on an off-label basis for otherwise treatment-refractory neuroimmunological disease. The chimeric anti-CD20 mAb rituximab

(MabThera®) is approved for haematological indications. In several countries, rituximab selleck screening library is recommended as first-line treatment for NMO, although not approved for this indication. For the malignant NMO disease course refractory to other treatment options, use of the IL-6-receptor mAb tocilizumab (RoActemra®, approved for rheumatoid arthritis) or the terminal complement inhibitor eculizumab (Soliris®, approved for paroxysmal nocturnal haemoglobinuria) has been

reported. Z-VAD-FMK order Especially for substances used on an off-label basis, patient selection is based on single-case decisions, sometimes supported by preclinical experimental data. Beneficial outcomes in smaller studies were reported for the anti-CD20 mAb rituximab in different neurological autoimmune conditions such as RRMS [8, 15], NMO [86-88], myasthenia gravis [30, 89] and multi-focal motor neuropathy [90, 91]. In PPMS, only a subgroup of younger patients with focal inflammatory activity on cranial MRI appeared to have some benefit from rituximab treatment. There are some data on rituximab use in paediatric populations with different neuroimmunological conditions [92-94]. Treatment with the IL-6 receptor mAb tocilizumab was efficacious in single cases of NMO refractory to rituximab [23, 95] and other neuroimmunological conditions [96-98]. Inhibition of the complement system via eculizumab has been tested in a small number of NMO patients with positive results. As mostly feared from treatment of paroxysmal nocturnal haemoglobinuria and atypical haemolytic uraemic syndrome, it was associated with one case of meningococcal sepsis from a total of 14 patients [27]. These concepts

will have to be confirmed in larger prospective Nintedanib (BIBF 1120) trials to evaluate efficacy and safety in neurological patient cohorts. Although formally off-label in each of the neuroimmunological disorders, rituximab is recommended as the first-line DMD for treatment of NMO in respective guidelines with two suggested regimens (haematological protocol 375 mg/m2 body surface area weekly over 4 weeks versus 2 × 1 g) [46, 99]. Adverse effects reported mainly from other indications are given in Table 1. Rituximab-associated PML cases are described in rheumatoid arthritis, systemic lupus erythematosus and haematological populations, with combined rituximab and immunosuppressants [100, 101]. However, the risk appears to be considerably lower than with NAT–PML in MS [101]. Due to the high frequency of infusion-related adverse events [102], newer anti-CD20 mAb have been studied on a Phase II level, the humanized ocrelizumab [17] and human ofatumumab [21]. Results of further studies are pending.

In conclusion, this study describes a new approach for investigat

In conclusion, this study describes a new approach for investigating neutrophil trafficking that can be used in preclinical studies to evaluate potential inhibitors of neutrophil recruitment. Polymorphonuclear (PMN) neutrophil transmigration across the mucosa and into intestinal crypts is a major characteristic of the inflammatory bowel diseases (IBD), Crohn’s disease (CD) and ulcerative colitis (UC). Excessive or unchecked neutrophil recruitment can lead to tissue damage, due mainly to the persistent release

of harmful inflammatory cytokines, reactive oxygen species and proteases by the infiltrated cells [1]. In active IBD, histological evidence of high-density neutrophil accumulation in the intestinal lumen RNA Synthesis inhibitor correlates directly with epithelial injury and clinical disease activity [2]. Therefore, targeting neutrophil influx is a potential therapeutic strategy for IBD. The CXC chemokines, human interleukin-8 (IL-8/CXCL8) and the murine functional homologues keratinocyte-derived chemokine (KC/CXCL1) and macrophage inflammatory protein-2 (MIP-2/CXCL2), are neutrophil chemoattractants that orchestrate their activation and recruitment from the blood into sites of infection, inflammation and injury by promoting endothelial adhesion and transmigration [3]. Their biological effects are mediated by binding to two high-affinity

receptors, CXCR1 and CXCR2 [4]. CXCR2 has proved Selleck RAD001 to be a potent mediator SPTLC1 of PMN recruitment in preclinical models of arthritis [5], allergy [6], respiratory disease [7] and ulcerative colitis [8]. Increased mucosal expression of these chemokine receptors and their ligands in IBD explains the massive influx of leucocytes in active disease. The up-regulation of IL-8 in the colonic mucosa of IBD patients [9,10] correlates well with the histological degree of inflammation and chemokine mRNA expression

[11,12]. The pivotal involvement of keratinocyte-derived chemokine (KC) and macrophage inflammatory protein-2 (MIP-2) in PMN infiltration into inflammatory sites is also well documented [13,14]. Furthermore, a marked increase in KC and MIP-2 have been reported in colons of mice with acute phase dextran sulphate sodium (DSS)-induced colitis [15]. Traditional methods used to track neutrophil recruitment, such as static histological analysis of fixed tissues following adoptive transfer of dye-labelled cells, do not provide temporal or spatial information within the physiological environment of lymphoid tissues [16]. While white cell scintigraphy has been used to study neutrophil migration in both preclinical and clinical IBD studies [17,18], there are well-recognised disadvantages associated with radiotracers including the adverse effect on cell viability, radioactive decay and poor resolution [19].

Several metabolites of the interaction between diet and host micr

Several metabolites of the interaction between diet and host microbiota, such as short-chain fatty acids, have been shown to play a fundamental role in shaping immune responses (reviewed in [11]). The application of microbial ecology concepts is ultimately leading to the conclusion that health and disease can be understood only through an understanding of the ways in which the symbiotic interactions between microbes DAPT and human organs harmonically integrate in the context

of the hologenome [12]. Human microbial diversity is not limited to bacteria; microorganisms such as fungi also play major roles in the stability of microbial communities in human health and disease (reviewed in [13]). Yeasts were detected in human stool samples as far back as 1917, and by the mid-20th century Inhibitor Library ic50 the presence of yeasts in the human intestine was proposed to have a saprotrophic role [14]. The mycobiota has been initially studied in animals, ranging from ruminants to insects, such as wasps [15] and termites. These studies paved

the way for understanding the role of fungal communities in humans. The limited data available thus far suggest that fungal communities are stable across time and are unique to individuals [16, 17]. Even if the available data are fragmentary because it relies mostly on culture-based methods, recent reports using next-generation sequencing technologies also suggest that diverse fungal communities exist in humans [16, 18]. Fungi and Blastocystis are the dominant (and in many cases the only) eukaryotes in the gut microbiota

of healthy individuals [16, 19]. More diversity will likely emerge when more individuals from diverse populations are sampled using next-generation sequencing, allowing detection of rare taxa. The first culture-independent analysis of the mycobiota populating a mammalian intestine revealed a previously unidentified diversity and Mannose-binding protein-associated serine protease abundance of fungal species in the murine gastrointestinal tract [17], indicating that fungi belonging to four major fungal phyla, Ascomycota, Basidiomycota, Chytridiomycota, and Zygomycota, account for approximately 2–3% of the total community present in a mucus biofilm. Many culture-dependent studies on various human niches have readily isolated yeasts, such as Candida spp., from the mouth, fingernail, toenail, and rectum of healthy hosts [20]. Microbial eukaryotes have also been suggested as the causative agents of diseases such as irritable bowel syndrome, inflammatory bowel disease (IBD), and “leaky gut” syndrome [16, 21, 22]. The primary aim of this review is to describe the fungal communities present in various body sites (Table 1) and the interaction of these fungi with the immune system.

gondii tachyzoite polyclonal antibody (37°C for 2 h) in a humidif

gondii tachyzoite polyclonal antibody (37°C for 2 h) in a humidified box. After washing the plates three times with PBST, fluorescein isothiocyanate (FITC)-labelled goat anti-mouse IgG (1 : 2000; Boster, Wuhan, China) was applied to all the cells and incubated at 37°C GSI-IX datasheet for 1 h. After washing the cells three more times with PBST, the fluorescence was observed under a fluorescence microscope (Olympus BX-51, Tokyo, Japan). Six- to eight-week-old female BALB/c mice were randomly divided

into three groups (13 mice per group) and immunized by intramuscular injection. pVAX1-TgCyP (100 μg/each in PBS) was used to immunize the mice for the experimental group (a 0·05 mL syringe and a 20G needle were used for the injection); the empty pVAX1 vector (100 μg/each in PBS) and PBS (100 μL/each) were used as negative controls. All groups were vaccinated in the same manner on days 0, 14 and 28. Blood was collected from each group via the venous plexus of the tail before each immunization and stored at −20°C Neratinib chemical structure for enzyme-linked immunosorbent assay (ELISA) analysis. An indirect ELISA test was applied to evaluate specific antibodies according

to the procedure described previously [12]. The 96-well microtiter plates were coated overnight at 4°C with crude T. gondii tachyzoite antigens (10 mg/mL). On the second day, the plates were blocked with 5% bovine serum albumin (BSA) in PBS at room temperature for 2 h. Then, the plates were washed three times with PBST, and incubated with mouse sera (1 : 3200 in 1% BSA-PBS) at 37°C for 1·5 h. After washing three times with PBST, the plates were incubated with an HRP-labelled goat anti-mouse IgG antibody (1 : 2000; Boster) at 37°C for 1 h. After washing three times with PBST, a substrate solution containing 15 μL H2O2, 10 ml citrate-phosphae

and 4 mg O-phenylenediamine (OPD) was applied (100 μL/well). The reaction was stopped with 2 m H2SO4, and the optical density values were read at A490. Spleens were removed from five mice per group 14 days after the final vaccination. A splenocyte old suspension was obtained by the gentle squeezing of whole spleens in Hank’s balanced salt solution (HBSS, Sigma, St. Louis, MO, USA) and filtration through nylon mesh. The erythrocytes in the spleen cell suspension were removed by lysis and centrifugation. The pellet was washed three times with PBS and resuspended with complete RPMI-1640 medium supplemented with 10% FCS. The cells were cultured in 96-well Costar plates at a density of 103 cells/well. The splenocytes were stimulated with TLA (10 μg/mL), concanavalin A (Con A; 5 μg/mL; Sigma; positive control) or medium alone (negative control). After incubation with Alamar blue (10 μL/well) for 12 h, the plates were read at 570 nm with an ELISA reader. Lymphocyte proliferative responses were represented by a stimulation index (SI), which is the OD570 ration between stimulated cells and nonstimulated cells.

c ) Mast cell numbers typically average about 9–10/mm2 of intest

c.). Mast cell numbers typically average about 9–10/mm2 of intestinal mucosa in uninfected hamsters (18), and the values in Figure 3 for naïve control animals (Group 1) concur. Likewise Group 3 hamsters (primary abbreviated infection), which had been treated to remove worms on day 35, recovered almost completely by day 73, showing mast cell

densities much like those of naïve animals on both days 73 and 94 of the experiment. In marked contrast hamsters that had experienced the uninterrupted primary infection (Group 2) had markedly elevated levels of mast cells, approximately five times more cells per mm2 of mucosal tissue on both days 73 and 94 p.i. Group 4 animals (secondary infection only) did not have elevated mast cell densities www.selleckchem.com/products/MLN-2238.html on day 10 p.i., but by 31 days p.i. the numbers had increased approximately three fold. Unexpectedly, 10 days p.c. mast cell numbers in immunized, challenged hamsters (Group 5, primary + secondary infections) were much like those of the naïve animals and then rose only

slowly, although significantly, over the course of the remainder of the experiment (regression of mast cells/mm2 of mucosal tissue on days after challenge, confined to Group 5; Rp = 0·50, n = 20, β = 0·29 ± 0·118, t = 2·43, P = 0·026). Goblet cell numbers in naive hamsters usually average about 50–70/mm2 (18), and the values in Figure 4 for naive hamsters (Group 1) and those from which worms had been removed Fer-1 manufacturer Meloxicam (Group 3, primary abbreviated infection), fall comfortably within the normal range. In hamsters with an uninterrupted primary infection (Group 2), goblet cell numbers were two fold higher on day

73 p.i. and over three fold higher on day 94 p.i., and in Group 4, given only the second infection, they were about half as high on day 10 p.i. and twice as high on day 31 p.i. In contrast, hamsters in Group 5 (primary + secondary infection), goblet cell numbers on day 10 were within the naïve control range, but then climbed steeply to peak on day 24 more than four fold higher before dropping somewhat by day 31 p.c. The curve thus generated was best described by the quadratic equation y = −193·9 + 29·72x−0·6×2 (where y = goblet cells/mm2 and x = days after challenge); R2 = 52·2%, F2,17 = 11·36, P = 0·0007). Eosinophil counts averaged below 32 cells/mm2 in naive animals (Group 1), and in animals, which had been treated to remove worms (Group 3, primary abbreviated infection) the values were about twice higher, but averaging below 66 cells/mm2 (Figure 5). In contrast in hamsters with the uninterrupted primary infection (Group 2) on days 73 and 94 p.i., the eosinophil counts were 12·8 and 9·7-fold higher, respectively, relative to the appropriate naïve control group.

The BKCa-channel blocker, iberiotoxin alone or in combination wit

The BKCa-channel blocker, iberiotoxin alone or in combination with the H2O2 scavenger, polyethylene glycol catalase, reversed exercise training-enhanced dilation in collateral-dependent arterioles. Iberiotoxin-sensitive whole-cell K+ currents (i.e., BKCa-channel currents) were not different between smooth muscle cells of nonoccluded and collateral-dependent arterioles of sedentary and exercise trained groups. These data provide evidence that BKCa-channel activity contributes to exercise training-enhanced endothelium-dependent dilation in collateral-dependent coronary arterioles despite no change in smooth muscle BKCa-channel current.

Taken together, our findings suggest that a component of the bradykinin signaling pathway, which stimulates BKCa channels, is LBH589 mw enhanced by exercise training in collateral-dependent arterioles and suggest a potential role for H2O2 as the mediator. “
“To use the OZR model of the metabolic syndrome to determine the impact of dilator stimuli on MA of GA and MCA. We tested the hypothesis that increased oxidant stress and TxA2 exacerbate MA, and Nutlin-3a order prevent its blunting with dilator stimuli, in OZR. GA/MCA from OZR and LZR was pressurized ex vivo. MA was determined under control conditions

and following challenge with acetylcholine, hypoxia, and adenosine. Responses were also evaluated after pre-treatment with TEMPOL (antioxidant) and SQ-29548 (PGH2/TxA2 receptor antagonist). MA was increased (and dilator responses decreased) in GA/MCA from OZR, dependent on the endothelium

and ROS. In GA, the impact of ROS on MA and dilator effects was largely via TxA2, while in MCA, this appeared was more dependent on NO bioavailability. Intrinsic responses of GA/MCA to carbacyclin, U46619, and NO donors were similar between strains. A developing ROS-based endothelial dysfunction in MCA and GA of OZR contributes HAS1 to an enhanced MA of these vessels. Although treatment of GA/MCA with TEMPOL attenuates MA in OZR, the mechanistic contributors to altered MA, distal to ROS, differ between the two resistance vessels. “
“Microcirculation (2010) 17, 159–163. doi: 10.1111/j.1549-8719.2010.00028.x This edition of Microcirculation presents five current and emerging perspectives of the microcirculation in development, health, and disease. The onset of blood flow and pressure are central to cardiovascular development. These hemodynamic forces are explored in light of underlying molecular signaling pathways that affect vascular and cardiac cell shape and proliferation. Shear-induced strain exerted on the plasma membrane and cytoskeleton is transmitted to cell nuclei and thereby affects gene activation through mechanotransduction. Altered stiffness or disturbed surfaces of aberrant vascular cells may affect an array of vasculopathies through altered gene expression.

Recent work has shown that this TLR-2-dependent and Wolbachia-dep

Recent work has shown that this TLR-2-dependent and Wolbachia-dependent stimulation of inflammation can impart a selective advantage to the parasite through activating mast cells in the skin, which enhances the establishment of the parasite by increasing vascular permeability (Specht et al., 2011). Some have even suggested that Wolbachia-mediated inflammatory responses may act to block antinematode immunity (Hansen et al., 2011) and so contribute indirectly to the unusual longevity of filarial nematodes. Probably the most important outcome from the discovery of Wolbachia mutualism in filarial nematodes has been to create the opportunity to use antibiotics as a Anti-infection Compound Library purchase novel treatment for filarial diseases (Slatko

et al., 2010; Taylor et al., 2010). Treatment with tetracycline or rifamycin antibiotics results in the clearance of the endosymbiont from the nematode, leading

to the blockage of embryogenesis, sterilization of adult Cell Cycle inhibitor worms and the eventual death of the adult parasites, an outcome that has remained elusive with existing antinematode drugs. Existing treatment regimes require a 4-week course of doxycycline to deplete the bacteria. Although this produces a superior therapeutic efficacy compared with existing antinematode drugs with benefits to individual point-of-care treatment, the prolonged course of therapy together with contraindications in children and pregnant women restricts its use in widespread community mass drug administration (MDA) programmes. This stimulated the formation of the anti-Wolbachia (A-WOL) consortium in 2007, which was funded by the Bill and Melinda Gates Foundation to discover and develop new antiwolbachial drugs suitable for MDA control programmes. Currently, the A-WOL consortium has developed a portfolio of drug discovery projects with the potential to generate at least one new antiwolbachial chemotype for eventual deployment as a macrofilaricide and is evaluating more than 200 ‘hits’ from registered or re-purposed drugs to improve on existing regimes (http://www.a-wol.com/). The goals of this research are to deliver antiwolbachial therapy that can be used in endemic communities,

to sustain the achievements of existing control programmes and to provide the means to deliver the elimination of filarial diseases. Ticks are small arachnids in the order Ixodida, subclass Acarina. before They are ectoparasites, living by hematophagy on the blood of mammals, birds, reptiles and amphibians. The lifestyle of many Ixodid (hard) ticks, which are the important vectors and reservoirs of many human and veterinary pathogens, encompasses three primary stages of development: larval, nymphal and adult. Most ticks take a blood meal only three times in their life (lasting up to 10 years for some species). This type of feeding (almost always a sterile meal) slows down metabolism, and a very hard chitin covering makes ticks the walking ‘cans’ with very limited exchange with the environment.

The longer the animal survived, the more

The longer the animal survived, the more AG-14699 biofilm can be found within the ETT internal surface. Furthermore, during ineffective antimicrobial therapy, the severity of infection increases, more mucus is produced and, consequently, more biofilm accumulates within the tube. Indeed, in the control group, animals survived less in comparison with animals treated with linezolid (Table 1). However, in the latter group, linezolid achieved better rate of bacterial killing limiting bacterial biofilm development. In contrast, as a result

of the worse penetrability of vancomycin vs. linezolid into the respiratory secretions, pulmonary tissue, or biofilm (Cruciani et al., 1996; Jefferson et al., 2005), higher clumps of bacterial biofilm were found within the vancomycin group (Table 2). Vancomycin group had also the highest mean of total area analyzed as images depended on the amount of information available in each sample (Table 2). Furthermore, sublethal doses of vancomycin have recently been associated with increased biofilm production by Staphylococcus aureus, because of autolysis and eDNA release (Fig. 4; Hsu et al., 2011). Previous results of this animal model are consistent with our CLSM findings and confirm greater antimicrobial selleck products efficacy of linezolid likely due to its pharmacokinetic/pharmacodynamic (PK/PD) profile (Martinez-Olondris

et al., 2012). As clearly emphasized by experts on this field, in vivo biofilm models are necessary to better understand the implications of biofilms in human infections (Hall-Stoodley & Stoodley, 2009). As described by our findings, the use of CLSM in vivo provides essential information on the three-dimensional biofilm structure within the ETT internal lumen and potentially the intensity of the immune response. Of note, we observed biofilm clusters adherent and detached to the ETT surface (Figs 3-7). Other authors have previously described non-adherent bacterial aggregates (Lam et al., 1980; Singh et al., 2000; Worlitzsch et al.,

2002; Fux et al., 2004). Indeed, several studies Sitaxentan clearly described biofilm growing inside mucus in patients with cystic fibrosis (Yang et al., 2008; Hassett et al., 2010). Furthermore, the presence of mucus could enhance production of biofilm not necessarily attached to ETT surface (Landry et al., 2006). Thus, although further corroboration is needed, our findings imply greater risks for bacterial translocation into the airways. Additionally, considering that biofilm could develop associated with but not directly adherent to the ETT surface, the efficacy of ETT coated with antimicrobial agents could be reduced. A few potential limitations of this study deserve further clarification. First, although we analyzed a considerable number of images, we only analyzed a small number of ETT samples. Yet, results obtained are consistent with previous findings on this animal model.

Leucocyte arrest on endothelial cells is mediated by selectin bin

Leucocyte arrest on endothelial cells is mediated by selectin binding to endothelial lectins, resulting in slow rolling, followed by integrin-mediated arrest.45 Chemokine expression on the surface of endothelial cells triggers changes in leucocyte integrin affinity, resulting in rapid binding of β2-containing integrins to endothelial intercellular adhesion molecule-1 and α4-containing integrins to vascular cell adhesion molecule-1. Following arrest, there is rapid release of these integrin contacts allowing

leucocytes to move to endothelial cell junctions, and migrate through these junctions. Finally, phagocytes migrate through the tissue to bacterially infected areas. OPN or its fragments bind to the α4β1 and α9β1 integrins through the SLAYGLR sequence: these integrins

Rapamycin mw are important in all these steps of infiltration;46,47 hence OPN may be important in any of these aspects of phagocyte extravasation. The exact mechanism remains obscure, however, and further work is required to elucidate the molecular interactions. Important questions include whether OPN regulates the function of these cell types, or if its effect is mostly related to cell migration. The role of leucocyte extravasation in the development of mouse periapical lesions XAV-939 was explored using P/E selectin double-deficient mice.48 These animals developed extensive bone loss similar to the OPN-deficient mice. There were also extensive systemic effects, including splenomegaly, which was not observed in the OPN-deficient mice (data not shown) and a 50% decrease in neutrophil accumulation in the inflammatory site. Hence, the effect of OPN deficiency on neutrophil accumulation is not as severe as that of selectin deficiency,

perhaps reflecting the redundancy of the integrin ligands available for extravasation. These integrins undergo rapid changes in affinity for their ligands during inflammation, and it is not known how these changes affect the binding of OPN.45,49,50 CD44 isoforms are also implicated in the effects of OPN,51 and additionally there is evidence that an intracellular form of OPN may have physiological importance.36,52 At early times after infection, we observed Ixazomib ic50 increased expression of IL-1α and RANKL in infected tissues from OPN-deficient mice: both these cytokines are associated with inflammation-associated bone resorption.26,53 Hence, the mechanism of the increased bone resorption in these mice is probably related to the increased expression of IL-1α and RANKL: further work is needed to determine the cell types expressing these factors in endodontic infections and the role of OPN in their regulation. OPN has been shown to be required for bone resorption in mice in response to ovariectomy or hind-limb suspension,54,55 and this effect is probably the result of a defect in osteoclast function in the absence of OPN.